New Horizons Diagnostics Corp
Records under this name other than patents New Horizons Diagnostics Corp holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to New Horizons Diagnostics Corp
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,254,866 | Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract Formerly held Term ended Term ended Sep 1, 2020 · From the USPTO record | Term ended | Term ended Sep 1, 2020 | From the USPTO record |
| US 7,169,408 | Bandage composition containing phage associated lytic enzymes useful for treating dermatological infections Lapsed on the fee record Ended Jan 30, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jan 30, 2015 | From the USPTO record |
| US 6,432,444 | Use of bacterial phage associated lysing enzymes for treating dermatological infections Formerly held Lapsed on the fee record Ended Aug 13, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 13, 2014 | From the USPTO record |
| US 6,428,784 | Vaginal suppository for treating group B Streptococcus infection Formerly held Lapsed on the fee record Ended Aug 6, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 6, 2014 | From the USPTO record |
| US 6,423,299 | Composition for treatment of a bacterial infection of an upper respiratory tract Formerly held Lapsed on the fee record Ended Jul 23, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jul 23, 2014 | From the USPTO record |
| US 7,063,837 | Syrup composition containing phage associated lytic enzymes Formerly held Lapsed on the fee record Ended Jun 20, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jun 20, 2014 | From the USPTO record |
| US 6,395,504 | Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants Formerly held Lapsed on the fee record Ended May 28, 2014 · From the USPTO record | Lapsed on the fee record | Ended May 28, 2014 | From the USPTO record |
| US 7,687,069 | Time release patch containing phage associated lytic enzymes for treating bacterial infections of the skin Formerly held Lapsed on the fee record Ended Mar 30, 2014 · From the USPTO record | Lapsed on the fee record | Ended Mar 30, 2014 | From the USPTO record |
| US 7,014,850 | Nasal spray for treating streptococcal infections Formerly held Lapsed on the fee record Ended Mar 21, 2014 · From the USPTO record | Lapsed on the fee record | Ended Mar 21, 2014 | From the USPTO record |
| US 6,335,012 | Use of bacterial phage associated lysing enzymes for treating bacterial infections of the mouth and teeth Formerly held Lapsed on the fee record Ended Jan 1, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jan 1, 2014 | From the USPTO record |